Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000419167 | SCV000524286 | benign | not specified | 2016-09-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Phosphorus, |
RCV000578055 | SCV000679925 | benign | Alstrom syndrome | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000419167 | SCV000711903 | benign | not specified | 2016-03-21 | criteria provided, single submitter | clinical testing | p.Phe729Phe in exon 8 of ALMS1: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 77.44% (6674/8618) o f East Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac. broadinstitute.org; dbSNP rs7598901). |
Invitae | RCV000578055 | SCV000999963 | benign | Alstrom syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000578055 | SCV001769053 | benign | Alstrom syndrome | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002429397 | SCV002729445 | benign | Cardiovascular phenotype | 2018-12-21 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003959913 | SCV004773406 | likely benign | ALMS1-related disorder | 2020-02-10 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV000578055 | SCV001458911 | benign | Alstrom syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000419167 | SCV001741567 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000419167 | SCV001921401 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000419167 | SCV001929520 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000419167 | SCV001952250 | benign | not specified | no assertion criteria provided | clinical testing |